Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats
Open Access
- 28 June 2010
- journal article
- Published by Springer Science and Business Media LLC in Journal of Translational Medicine
- Vol. 8 (1), 63
- https://doi.org/10.1186/1479-5876-8-63
Abstract
Background: The therapeutic effect of adipose-derived mesenchymal stem cells (ADMSCs) on brain infarction area (BIA) and neurological status in a rat model of acute ischemic stroke (IS) was investigated. Methods: Adult male Sprague-Dawley (SD) rats (n = 30) were divided into IS plus intra-venous 1 mL saline (at 0, 12 and 24 h after IS induction) (control group) and IS plus intra-venous ADMSCs (2.0 × 106) (treated interval as controls) (treatment group) after occlusion of distal left internal carotid artery. The rats were sacrificed and brain tissues were harvested on day 21 after the procedure. Results: The results showed that BIA was larger in control group than in treatment group (p < 0.001). The sensorimotor functional test (Corner test) identified a higher frequency of turning movement to left in control group than in treatment group (p < 0.05). mRNA expressions of Bax, caspase 3, interleukin (IL)-18, toll-like receptor-4 and plasminogen activator inhibitor-1 were higher, whereas Bcl-2 and IL-8/Gro were lower in control group than in treatment group (all p < 0.05). Western blot demonstrated a lower CXCR4 and stromal-cell derived factor-1 (SDF-1) in control group than in treatment group (all p < 0.01). Immunohistofluorescent staining showed lower expressions of CXCR4, SDF-1, von Willebran factor and doublecortin, whereas the number of apoptotic nuclei on TUNEL assay was higher in control group than in treatment group (all p < 0.001). Immunohistochemical staining showed that cellular proliferation and number of small vessels were lower but glial fibrillary acid protein was higher in control group than in treatment group (all p < 0.01). Conclusions: ADMSC therapy significantly limited BIA and improved sensorimotor dysfunction after acute IS.Keywords
This publication has 35 references indexed in Scilit:
- CD133 Identifies a Human Bone Marrow Stem/Progenitor Cell Sub-population With a Repertoire of Secreted Factors That Protect Against StrokeMolecular Therapy, 2009
- Stem cell‐based cell therapy in neurological diseases: A reviewJournal of Neuroscience Research, 2009
- Transplanted bone marrow stromal cells migrate, differentiate and improve motor function in rats with experimentally induced cerebral strokeJournal of Anatomy, 2008
- Cloning and expression pattern of dog SDF-1 and the implications of altered expression of SDF-1 in ischemic myocardiumCytokine, 2007
- Guidelines for the Early Management of Adults With Ischemic StrokeStroke, 2007
- Two Tales: Hemorrhagic Transformation but Not Parenchymal Hemorrhage After Thrombolysis Is Related to Severity and Duration of IschemiaStroke, 2007
- Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defectJCI Insight, 2006
- Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulationBlood, 2004
- Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in ratsExperimental Neurology, 2003
- Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantationThe Lancet, 2003